Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cardiovascular Systems
MedTech
TCT: Abbott atherectomy study fails vs. balloon angioplasty
The Diamondback 360 is designed to etch away at severely calcified lesions, where hardened plaques can make it difficult to expand a heart stent.
Conor Hale
Oct 29, 2024 12:30pm
Abbott to acquire Cardiovascular Systems for $890M
Feb 9, 2023 10:45am
Cardiovascular Systems plots moves into blood clot removal
Feb 23, 2022 11:24am
Cardiovascular Systems recalls faulty embolic protection devices
Jan 11, 2022 11:28am
Coyle exits Medtronic to run iRhythm
Dec 15, 2020 7:50am
Merit to sell Bluegrass Vascular catheter system in Europe
Mar 6, 2017 11:19am
